Biovista

Biovista is a pioneer of AI and systematic drug repositioning, drug de-risking disease cohort analysis, and clinical hold analysis services.

Headquarters

Year Founded

Search Tags

drug repositioning, personalized medicine, AI in healthcare

About Us

Biovista is a company focused on advancing healthcare through drug repositioning and personalized medicine. By leveraging artificial intelligence and advanced analytics, Biovista identifies new uses for existing drugs and optimizes treatments for specific patient needs. 

Trending Companies

Latest Articles

Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.